WASHINGTON – The Senate on Thursday, without fanfare or controversy, approved legislation that will keep many Food and Drug Administration operations running and deliver a significant win to the pharmaceutical industry. Lawmakers voted 94-1 to approve the so-called “user fee agreements” that govern how much private drug and device makers pay in fees to support the…